Combined Dipeptidyl Peptidase 4 Inhibitor and α-Glucosidase Inhibitor Treatment in Postprandial Hypoglycemia.
作者信息
Broome David T, Kodali Alimitha, Phillips Danielle, Makin Vinni, Mendlovic Daniel, Zimmerman Robert S
机构信息
Department of Endocrinology, Diabetes & Metabolism, Cleveland Clinic Foundation, Cleveland, OH.
Cleveland Clinic Anesthesiology Institute, Cleveland Clinic Foundation, Cleveland, OH.
出版信息
Clin Diabetes. 2022 Jan;40(1):116-119. doi: 10.2337/cd21-0042.
Abstract
摘要
相似文献
1
Combined Dipeptidyl Peptidase 4 Inhibitor and α-Glucosidase Inhibitor Treatment in Postprandial Hypoglycemia.
Clin Diabetes. 2022 Jan;40(1):116-119. doi: 10.2337/cd21-0042.
2
Comparison of efficacies of a dipeptidyl peptidase IV inhibitor and alpha-glucosidase inhibitors in oral carbohydrate and meal tolerance tests and the effects of their combination in mice.
J Pharmacol Sci. 2007 May;104(1):29-38. doi: 10.1254/jphs.fp0061376. Epub 2007 May 8.
3
Cerebrovascular Complications of Diabetes: Alpha Glucosidase Inhibitor as Potential Therapy.
Horm Metab Res. 2016 Feb;48(2):83-91. doi: 10.1055/s-0035-1565181. Epub 2015 Nov 17.
4
Synergistic effect of α-glucosidase inhibitors and dipeptidyl peptidase 4 inhibitor treatment.
J Diabetes Investig. 2011 Jun 5;2(3):200-3. doi: 10.1111/j.2040-1124.2010.00081.x.
5
Steroidal saponins from Trillium govanianum as α-amylase, α-glucosidase, and dipeptidyl peptidase IV inhibitory agents.
J Pharm Pharmacol. 2021 Mar 8;73(4):487-495. doi: 10.1093/jpp/rgaa038.
6
[Hypoglycemia in the diabetes treatment - risk minimization with dipeptidyl peptidase-4 inhibitors].
Drugs Today (Barc). 2010 Dec;46 Suppl F:1-12.
7
Inhibitory effect of chestnut (Castanea mollissima Blume) inner skin extract on the activity of α-amylase, α-glucosidase, dipeptidyl peptidase IV and in vitro digestibility of starches.
Food Chem. 2020 Sep 15;324:126847. doi: 10.1016/j.foodchem.2020.126847. Epub 2020 Apr 18.
8
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial.
J Diabetes Investig. 2015 Mar;6(2):182-91. doi: 10.1111/jdi.12282. Epub 2014 Sep 24.
9
The Inhibitory Effects of New Zealand Pine Bark (Enzogenol) on α-Amylase, α-Glucosidase, and Dipeptidyl Peptidase-4 (DPP-4) Enzymes.
Nutrients. 2022 Apr 12;14(8):1596. doi: 10.3390/nu14081596.
10
Anti-α-glucosidase and Anti-dipeptidyl Peptidase-IV Activities of Extracts and Purified Compounds from Vitis thunbergii var. taiwaniana.
J Agric Food Chem. 2015 Jul 22;63(28):6393-401. doi: 10.1021/acs.jafc.5b02069. Epub 2015 Jul 13.
本文引用的文献
1
Postprandial Reactive Hypoglycemia.
Sisli Etfal Hastan Tip Bul. 2019 Aug 28;53(3):215-220. doi: 10.14744/SEMB.2019.59455. eCollection 2019.
2
Global status of diabetes prevention and prospects for action: A consensus statement.
Diabetes Metab Res Rev. 2018 Sep;34(6):e3021. doi: 10.1002/dmrr.3021. Epub 2018 Jun 8.
3
[Sitaglitpin phosphate treatment in patients with reactive hypoglycemia secondary to dysinsulinism. Controlled, randomized, double-blind study].
Gac Med Mex. 2017;153(Supl. 2):S51-S59. doi: 10.24875/GMM.M17000007.
4
Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta-analysis.
J Diabetes Investig. 2018 Jul;9(4):893-902. doi: 10.1111/jdi.12754. Epub 2017 Oct 25.
5
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
Cochrane Database Syst Rev. 2017 May 10;5(5):CD012204. doi: 10.1002/14651858.CD012204.pub2.
6
Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal.
BMC Endocr Disord. 2016 Sep 29;16(1):55. doi: 10.1186/s12902-016-0133-7.
7
Sitagliptin improves glycaemic excursion after a meal or after an oral glucose load in Japanese subjects with impaired glucose tolerance.
Diabetes Obes Metab. 2015 Nov;17(11):1033-41. doi: 10.1111/dom.12507. Epub 2015 Jul 17.
8
Idiopathic accelerated gastric emptying presenting in adults with post-prandial diarrhea and reactive hypoglycemia: a case series.
J Med Case Rep. 2012 May 19;6:132. doi: 10.1186/1752-1947-6-132.
9
Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.
Diabetes Care. 2008 Jan;31(1):30-5. doi: 10.2337/dc07-1616. Epub 2007 Oct 18.
10
Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes.
Diabetes. 2007 May;56(5):1475-80. doi: 10.2337/db07-0136. Epub 2007 Feb 15.
Zotero 插件